BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33990121)

  • 41. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
    Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
    Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome.
    Moran CA; Southmayd G; Devireddy CM; Quyyumi AA; Ofotokun I; Liberman HA; Jaber W; Sheth AN
    AIDS; 2020 Jan; 34(1):81-90. PubMed ID: 31634195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.
    Slama L; Palella FJ; Abraham AG; Li X; Vigouroux C; Pialoux G; Kingsley L; Lake JE; Brown TT
    J Antimicrob Chemother; 2014 Dec; 69(12):3360-7. PubMed ID: 25096078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case-control study of diabetes mellitus in HIV-infected patients.
    Yoon C; Gulick RM; Hoover DR; Vaamonde CM; Glesby MJ
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1464-9. PubMed ID: 15602124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study.
    Harding BN; Whitney BM; Nance RM; Ruderman SA; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer KH; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
    BMC Infect Dis; 2020 Mar; 20(1):238. PubMed ID: 32197585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
    Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
    J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.
    Jain MK; Aragaki C; Fischbach L; Gibson S; Arora R; May L; Vardhineni K; Lee WM
    HIV Med; 2007 Nov; 8(8):491-7. PubMed ID: 17944681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
    Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
    AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brief Report: Prevalence of Peripheral Artery Disease Is Higher in Persons Living With HIV Compared With Uninfected Controls.
    Knudsen AD; Gelpi M; Afzal S; Ronit A; Roen A; Mocroft A; Lundgren J; Nordestgaard B; Sillesen H; Lebech AM; Køber L; Kofoed KF; Nielsen SD
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):381-385. PubMed ID: 29985264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.
    Samad F; Harris M; Puskas CM; Ye M; Chia J; Chacko S; Bondy GP; Lima VD; Montaner JS; Guillemi SA
    BMJ Open Diabetes Res Care; 2017; 5(1):e000457. PubMed ID: 29225896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and risk factors associated with HIV and syphilis co-infection in the African Cohort Study: a cross-sectional study.
    Gilbert L; Dear N; Esber A; Iroezindu M; Bahemana E; Kibuuka H; Owuoth J; Maswai J; Crowell TA; Polyak CS; Ake JA;
    BMC Infect Dis; 2021 Oct; 21(1):1123. PubMed ID: 34717564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection.
    McLaughlin MM; Ma Y; Scherzer R; Rahalkar S; Martin JN; Mills C; Milush J; Deeks SG; Hsue PY
    JAMA Netw Open; 2020 Oct; 3(10):e2018099. PubMed ID: 33119103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
    Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validity of hemoglobin A1c for diagnosing diabetes among people with and without HIV in Uganda.
    Muchira J; Stuart-Shor E; Manne-Goehler J; Lo J; Tsai AC; Kakukire B; Okello S; Siedner MJ
    Int J STD AIDS; 2019 Apr; 30(5):479-485. PubMed ID: 30714875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
    Brar I; Shuter J; Thomas A; Daniels E; Absalon J;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):66-71. PubMed ID: 17245229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.
    Liu P; Dillingham R; McManus K
    AIDS Res Ther; 2017; 14():25. PubMed ID: 28469696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes Changes Symptoms Cluster Patterns in Persons Living With HIV.
    Zuniga JA; Bose E; Park J; Lapiz-Bluhm MD; García AA
    J Assoc Nurses AIDS Care; 2017; 28(6):888-896. PubMed ID: 28765048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.
    Hardy YO; Libhaber E; Ofori E; Amenuke DAY; Kontoh SA; Dankwah JA; Larsen-Reindorf R; Otu-Ansah C; Hutton-Mensah K; Dadson E; Adamu S; Akyerekoh K; Sarfo FS; Nkum B
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e391. PubMed ID: 36426913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.